ARCHIVES

Cancer Groups Criticize FDA For Ignoring Expert Advice.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

July 22, 2011

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977